Improving cancer trial enrollment for Black and Latino patients
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
This study is testing a new support program to help Black and Latino cancer patients learn about and join clinical trials more easily.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Eastern Cooperative Oncology Group Research network |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06756607 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the EA SUPPORT intervention, which combines clinical trial navigators and research literacy tools, in enhancing the referral and enrollment of Black and Latino cancer patients in NCI-supported clinical trials. Conducted at NCORP community oncology practice sites, the trial aims to include 500 participants and assess both primary outcomes related to trial enrollment and secondary outcomes concerning awareness and knowledge of clinical trials among patients and providers. The study also focuses on implementation factors and aims to disseminate the SUPPORT intervention across various oncology networks.
Who should consider this trial
Good fit: Ideal candidates for this study are Black and Latino cancer patients aged 18 and older who are receiving care at participating NCORP community oncology sites.
Not a fit: Patients who do not self-identify as Black or Latino or those who are not receiving care at a participating NCORP site may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly increase the participation of underrepresented populations in cancer clinical trials, leading to more equitable healthcare outcomes.
How similar studies have performed: Other studies have shown success in improving clinical trial enrollment through targeted interventions, making this approach promising yet still innovative in its specific focus on diverse populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Participant must be ≥ 18 years of age. Participant must self-identify as Black and/or Latino. Participant must be an oncology patient at a participating NCORP. Participant must be eligible to participate in an ECOG-ACRIN clinical trial. Participant must have the ability to understand and the willingness to sign a e-consent document. Participant must be receiving care at a participating NCORP affiliated community oncology site. Participant must be English or Spanish speaking to be eligible. Participant must have access to a landline, smartphone, computer, or tablet. Exclusion Criteria: \-
Where this trial is running
Chicago, Illinois
- Northwestern University — Chicago, Illinois, United States (Recruiting)
Study contacts
- Study coordinator: Melissa A Simon, MD, MPH
- Email: m-simon2@northwestern.edu
- Phone: (312) 503-8780
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.